Histone variant macroH2A1 deletion in mice causes female-specific steatosis

Epigenetics and Chromatin

Volumn 3, Issue 1, 2010, Pages

  Boulard, Mathieu ^a,b   Storck, Sébastien ^a,b   Cong, Rong ^a,b,c   Pinto, Rodrigo ^a,b   Delage, Hélène ^a,b   Bouvet, Philippe ^a,b  

^a Laboratoire Joliot Curie   (France)

^b UNIVERSITÉ DE LYON   (France)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2A; MACROH2A1; THYROXINE; THYROXINE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MODIFICATION; DNA REPAIR; ENERGY METABOLISM; FATTY LIVER; FEMALE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC VARIABILITY; HOMEOSTASIS; HOMOZYGOTE; LIPID STORAGE; MALE; MOUSE; NONHUMAN; NUCLEOSOME; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; UPREGULATION; WILD TYPE; X CHROMOSOME LINKAGE;

ANIMALIA; MAMMALIA; MURINAE; MUS; VERTEBRATA;

EID: 77953378893     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-3-8     Document Type: Article

References (40)

1. MacroH2A, a core histone containing a large nonhistone region. JR Pehrson VA Fried, Science 1992 257 1398 1400 10.1126/science.1529340 1529340
2. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. C Costanzi JR Pehrson, Nature 1998 393 599 601 10.1038/31275 9634239 (Pubitemid 28319252)
3. Histone macroH2A1.2 relocates to the inactive X chromosome after initiation and propagation of X-inactivation. JE Mermoud C Costanzi JR Pehrson N Brockdorff, J Cell Biol 1999 147 1399 1408 10.1083/jcb.147.7.1399 10613899 (Pubitemid 30027396)
4. Weak, but uniform enrichment of the histone variant macroH2A1 along the inactive X chromosome. F Mietton AK Sengupta A Molla G Picchi S Barral L Heliot T Grange A Wutz S Dimitrov, Mol Cell Biol 2008 29 150 6 10.1128/MCB.00997-08 18936163
5. Dynamic relocalization of histone MacroH2A1 from centrosomes to inactive X chromosomes during X inactivation. TP Rasmussen MA Mastrangelo A Eden JR Pehrson R Jaenisch, J Cell Biol 2000 150 1189 1198 10.1083/jcb.150.5.1189 10974005
6. Messenger RNAs encoding mouse histone macroH2A1 isoforms are expressed at similar levels in male and female cells and result from alternative splicing. TP Rasmussen T Huang MA Mastrangelo J Loring B Panning R Jaenisch, Nucleic Acids Res 1999 27 3685 3689 10.1093/nar/27.18.3685 10471737 (Pubitemid 29435748)
7. The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. D Angelov A Molla PY Perche F Hans J Cote S Khochbin P Bouvet S Dimitrov, Mol Cell 2003 11 1033 1041 10.1016/S1097-2765(03) 00100-X 12718888 (Pubitemid 36566324)
8. MacroH2A allows ATP-dependent chromatin remodeling by SWI/SNF and ACF complexes but specifically reduces recruitment of SWI/SNF (dagger). EY Chang H Ferreira J Somers DA Nusinow T Owen-Hughes GJ Narlikar, Biochemistry 2008 47 13726 32 10.1021/bi8016944 19035833
9. Mechanism of polymerase II transcription repression by the histone variant macroH2A. CM Doyen W An D Angelov V Bondarenko F Mietton VM Studitsky A Hamiche RG Roeder P Bouvet S Dimitrov, Mol Cell Biol 2006 26 1156 1164 10.1128/MCB.26.3.1156-1164.2006 16428466 (Pubitemid 43146506)
10. Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. M Agelopoulos D Thanos, EMBO J 2006 25 4843 4853 10.1038/sj.emboj.7601364 17036053 (Pubitemid 44607029)
11. MacroH2A1 knockdown effects on the Peg3 imprinted domain. JH Choo JD Kim J Kim, BMC Genomics 2007 8 479 10.1186/1471-2164-8-479 18166131 (Pubitemid 351250489)
12. The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. K Ouararhni R Hadj-Slimane S Ait-Si-Ali P Robin F Mietton A Harel-Bellan S Dimitrov A Hamiche, Genes Dev 2006 20 3324 3336 10.1101/gad.396106 17158748 (Pubitemid 44904853)
13. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. MJ Gamble KM Frizzell C Yang R Krishnakumar WL Kraus, Genes Dev 2009 24 21 32 10.1101/gad.1876110 20008927
14. macroH2A1-dependent silencing of endogenous murine leukemia viruses. LN Changolkar G Singh JR Pehrson, Mol Cell Biol 2008 28 2059 2065 10.1128/MCB.01362-07 18195046 (Pubitemid 351342635)
15. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. AJ Barbera JV Chodaparambil B Kelley-Clarke V Joukov JC Walter K Luger KM Kaye, Science 2006 311 856 861 10.1126/science.1120541 16469929 (Pubitemid 43228851)
16. Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. DA Nusinow I Hernandez-Munoz TG Fazzio GM Shah WL Kraus B Panning, J Biol Chem 2007 282 12851 12859 10.1074/jbc.M610502200 17322296 (Pubitemid 47100579)
17. Poly(ADP-ribose): novel functions for an old molecule. V Schreiber F Dantzer JC Ame G de Murcia, Nat Rev Mol Cell Biol 2006 7 517 528 10.1038/nrm1963 16829982 (Pubitemid 44036457)
18. Splicing regulates NAD metabolite binding to histone macroH2A. G Kustatscher M Hothorn C Pugieux K Scheffzek AG Ladurner, Nat Struct Mol Biol 2005 12 624 625 10.1038/nsmb956 15965484 (Pubitemid 40980814)
19. MACROH2A2, a new member of the MACROH2A core histone family. C Costanzi JR Pehrson, J Biol Chem 2001 276 21776 21784 10.1074/jbc.M010919200 11262398 (Pubitemid 37413180)
20. Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant. BP Chadwick HF Willard, Hum Mol Genet 2001 10 1101 1113 10.1093/hmg/10.10.1101 11331621
21. The histone variant macroH2A is an epigenetic regulator of key developmental genes. M Buschbeck I Uribesalgo I Wibowo P Rue D Martin A Gutierrez L Morey R Guigo H Lopez-Schier L Di Croce, Nat Struct Mol Biol 2009 16 1074 9 10.1038/nsmb.1665 19734898
22. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. M den Boer PJ Voshol F Kuipers LM Havekes JA Romijn, Arterioscler Thromb Vasc Biol 2004 24 644 649 10.1161/01.ATV.0000116217.57583.6e 14715643 (Pubitemid 38451598)
23. Developmental changes in histone macroH2A1-mediated gene regulation. LN Changolkar C Costanzi NA Leu D Chen KJ McLaughlin JR Pehrson, Mol Cell Biol 2007 27 2758 2764 10.1128/MCB.02334-06 17242180 (Pubitemid 46581363)
24. Lipoprotein lipase: genetics, lipid uptake, and regulation. M Merkel RH Eckel IJ Goldberg, J Lipid Res 2002 43 1997 2006 10.1194/jlr.R200015-JLR200 12454259 (Pubitemid 35471065)
25. S14: insights from knockout mice. LT LaFave LB Augustin CN Mariash, Endocrinology 2006 147 4044 4047 10.1210/en.2006-0473 16809440
26. The evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis. G Schreiber, J Endocrinol 2002 175 61 73 10.1677/joe.0.1750061 12379491 (Pubitemid 35276587)
27. Metabolic effects of thyroid hormone derivatives. M Moreno P de Lange A Lombardi E Silvestri A Lanni F Goglia, Thyroid 2008 18 239 253 10.1089/thy.2007.0248 18279024 (Pubitemid 351271526)
28. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. IP Pogribny VP Tryndyak TV Bagnyukova S Melnyk B Montgomery SA Ross JR Latendresse I Rusyn FA Beland, J Hepatol 2009 51 176 186 10.1016/j.jhep.2009.03.021 19450891
29. The histone variant macroH2A is an epigenetic regulator of key developmental genes. M Buschbeck I Uribesalgo I Wibowo P Rue D Martin A Gutierrez L Morey R Guigo H Lopez-Schier L Di Croce, Nat Struct Mol Biol 2009 16 1074 1079 10.1038/nsmb.1665 19734898
30. Variation in Xi chromatin organization and correlation of the H3K27 me3 chromatin territories to transcribed sequences by microarray analysis. BP Chadwick, Chromosoma 2007 116 147 157 10.1007/s00412-006-0085-1 17103221
31. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. U Muller, Mech Dev 1999 82 3 21 10.1016/S0925-4773(99) 00021-0 10354467 (Pubitemid 29243049)
32. Gene amplification as a cause of inherited thyroxine-binding globulin excess in two Japanese families. Y Mori Y Miura H Takeuchi Y Igarashi J Sugiura H Saito Y Oiso, J Clin Endocrinol Metab 1995 80 3758 3762 10.1210/jc.80.12.3758 8530630
33. Studies on human thyroxine-binding globulin (TBG). IX. Some physical, chemical, and biological properties of radioiodinated TBG and partially desialylated TBG. S Refetoff VS Fang JS Marshall, J Clin Invest 1975 56 177 187 10.1172/JCI108066 806610
34. Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. I Hernandez-Munoz AH Lund P van der Stoop E Boutsma I Muijrers E Verhoeven DA Nusinow B Panning Y Marahrens M van Lohuizen, Proc Natl Acad Sci USA 2005 102 7635 7640 10.1073/pnas.0408918102 15897469 (Pubitemid 40741023)
35. Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation. G Csankovszki B Panning B Bates JR Pehrson R Jaenisch, Nat Genet 1999 22 323 324 10.1038/11887 10431231 (Pubitemid 29369518)
36. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. K Tateishi Y Okada EM Kallin Y Zhang, Nature 2009 458 757 761 10.1038/nature07777 19194461
37. SirT1 regulates energy metabolism and response to caloric restriction in mice. G Boily EL Seifert L Bevilacqua XH He G Sabourin C Estey C Moffat S Crawford S Saliba K Jardine J Xuan M Evans ME Harper MW McBurney, PLoS ONE 2008 3 1759 10.1371/journal.pone.0001759 18335035 (Pubitemid 351903300)
38. Laboratory Protocols for Conditional Gene Targeting. RMaKR Torres, Oxford University Press, Oxford, UK 1997
39. Functional proteomic analysis of human nucleolus. A Scherl Y Coute C Deon A Calle K Kindbeiter JC Sanchez A Greco D Hochstrasser JJ Diaz, Mol Biol Cell 2002 13 4100 4109 10.1091/mbc.E02-05-0271 12429849 (Pubitemid 35398573)
40. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. J Pothlichet M Mangeney T Heidmann, Int J Cancer 2006 119 1869 1877 10.1002/ijc.22066 16708391 (Pubitemid 44356845)